TEJON WOODS: Open Payments
NPI 1285911214 · REDLANDS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,977 in 187 payments from 18 companies in 2025. Trend: 2023 $50 · 2024 $3,041 · 2025 $4,977
Food & beverage: $4,977
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 42 | $878 |
| Vanda Pharmaceuticals Inc. | 18 | $698 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $513 |
| Teva Pharmaceuticals USA, Inc. | 18 | $510 |
| E.R. Squibb & Sons, L.L.C. | 18 | $504 |
| Janssen Pharmaceuticals, Inc | 11 | $454 |
| ABBVIE INC. | 27 | $448 |
| Alkermes, Inc. | 12 | $387 |
| Axsome Therapeutics, Inc. | 16 | $246 |
| Janssen Biotech, Inc. | 1 | $123 |
Products named: INVEGA SUSTENNA, HETLIOZ, CAPLYTA, COBENFY, REXULTI, VRAYLAR, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
